Chrome Extension
WeChat Mini Program
Use on ChatGLM

LIBRETTO-432: A Phase 3 Study of Adjuvant Selpercatinib or Placebo in Stage IB-IIIA RET Fusion-Positive (RET+) NSCLC.

JOURNAL OF CLINICAL ONCOLOGY(2024)

Cited 0|Views3
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined